Western Pacific Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
JFG
Western Pacific Wealth Management's ARKG Position: Q2 2026 in Review
Western Pacific Wealth Management held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 10 shares worth $421. The position accounts for ﹤0.01% of the portfolio, ranked #177.
Western Pacific Wealth Management first reported a position in ARKG in Q1 2022 and has held it in 18 quarters since. The position peaked at $10.2K in Q4 2023. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.
- Western Pacific Wealth Management held 10 shares of ARK Genomic Revolution ETF worth $421 as of Q2 2026.
- Western Pacific Wealth Management left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
- ARK Genomic Revolution ETF made up ﹤0.01% of Western Pacific Wealth Management's portfolio in Q2 2026, its #177 holding.
- Western Pacific Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2022 and has held it in 18 quarters since.
- Western Pacific Wealth Management's ARK Genomic Revolution ETF position peaked at $10.2K in Q4 2023.
- 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.
Based on Western Pacific Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.